ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 676825 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 676825; 2) Community: the network communities that were significantly associated with the response to NSC 676825; 3) Molecule: the relationships between components within communities and NSC 676825; 4) MDR: the compounds that were significantly associated with the NSC 676825.

NSC Compound Enrichment Correlation
NSC 625731 Null 0.0352786308082228 0.16715272
NSC 626879 Cyclopentanone, 2-[(dimethylamino)methyl]-5-heptylidene-, hydrochloride 0.0352786308082228 0.10968613
NSC 641245 Benzenebutanamide, N-(3-chloro-1,4-dihydro-1,4-dioxo- 2-naphthalenyl)-.alpha.,.gamma.-dioxo-2-(3,4-dihydro- 3,4-dioxo-2-naphthalenyl)- 0.0352786308082228 -0.053027566
NSC 114512 Null 0.0415729612483928 -0.062260917
NSC 119875 Cisplatin 0.0415729612483928 -0.070501449
NSC 140701 Sulfanilanilide, 4'-(9-acridinylamino)-, monohydrochloride 0.0415729612483928 0.0014084917
NSC 176507 Fastigilin C 0.0415729612483928 0.027431815
NSC 255104 Des-O-methylgeldanamycin 0.0415729612483928 0.049951851
NSC 274553 Null 0.0415729612483928 -0.029873154
NSC 276371 2,5-Cyclohexadiene-1,4-dione, 2,3-dimethoxy-5-[(3,7,11,15-tetramethyl-2-hexadecenyl)thio]-, [R-[R*,R*-(E)]]- 0.0415729612483928 -0.079913288
Total:59  Current:42    [First] [Prev] [Next] [Last]